Jan Heyckendorf

12PUBLICATIONS
21CO-AUTHORS
Haematological tumoursGene and molecular therapyGene expression (incl. microarray and other genome-wide approaches)NanomedicineGenomics and transcriptomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 28, 2022
Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19.

Florian Tran, Danielle M M Harris, Alena Scharmacher

|Nov 24, 2022
Long-term multidrug- and rifampicin-resistant tuberculosis treatment outcome by new WHO definitions in Germany.

Ralf Otto-Knapp, Brit Häcker, David Krieger

|Feb 16, 2022
Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes.

Andrew R DiNardo, Tanmay Gandhi, Jan Heyckendorf

|Sep 10, 2021
Emergence of bedaquiline resistance in a high tuberculosis burden country.

Elena Chesov, Dumitru Chesov, Florian P Maurer

|May 27, 2021
Perspectives for systems biology in the management of tuberculosis.

Irina Kontsevaya, Christoph Lange, Patricia Comella-Del-Barrio

|Feb 12, 2021
Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model.

Jan Heyckendorf, Sebastian Marwitz, Maja Reimann

Pageof 2